Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RALOXIFENE vs RAMIPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RALOXIFENE vs RAMIPRIL: Safety Overview

Metric RALOXIFENE RAMIPRIL
Total FAERS Reports 4,185 33,063
Deaths Reported 34 3,786
Death Rate 0.8% 11.5%
Hospitalizations 346 17,747
Average Patient Age 67.7 yrs 65.4 yrs
% Female Patients 99.7% 53.1%
FDA Approval Date Apr 8, 2016 Apr 15, 2014
Manufacturer American Health Packaging GSMS, Incorporated
Route ORAL ORAL
Marketing Status Prescription Discontinued